ArticleGynecologic oncology reports2019

Assessing recurrence risk following intraperitoneal chemotherapy for ovarian cancer: A day late and a dollar short?

Charles A Leath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.